The splicing factor U2AF1 contributes to cancer progression through a noncanonical role in translation regulation.
Lab co-author: Katie Lindblad
Molecular Measurable Residual Disease Testing of Blood During AML Cytotoxic Therapy for Early Prediction of Clinical Response.
Lab first author: Hong Yuen
Lab co-authors: Katie Lindblad, Sheenu, Greg, Meg, Matt, Nestor, Jingrong, Julie, Blair, Laura and Katie Lai.
MDS-associated mutations in germline GATA2 mutated patients with hematologic manifestations.
Lab Co-authors: Hong Yuen, Jingrong, Matt.
Refining AML outcome prediction.
With more to come soon….